A genetic score for the prediction of beta-thalassemia severity

Haematologica

Volumn 100, Issue 4, 2015, Pages 452-457

  Danjou, Fabrice ^a   Francavilla, Marcella ^a   Anni, Franco ^a   Satta, Stefania ^a   Demartis, Franca Rosa ^a   Perseu, Lucia ^b   Manca, Matteo ^b   Sollaino, Maria Carla ^b   Manunza, Laura ^a   Mereu, Elisabetta ^a   Marceddu, Giuseppe ^a   Pissard, Serge ^c   Joly, Philippe ^d   Thuret, Isabelle ^e   Origa, Raffaella ^a   Borg, Joseph ^f   Forni, Gian Luca ^g   Piga, Antonio ^h   Lai, Maria Eliana ^b   Badens, Catherine ^e   Moi, Paolo ^a,b   Galanello, Renzo ^a,b   more..

^a UNIVERSITY OF CAGLIARI   (Italy)

^b Osp Regionale per le Microcitemie   (Italy)

^c HENRI MONDOR HOSPITAL   (France)

^d EDOUARD HERRIOT HOSPITAL   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^f UNIVERSITY OF MALTA   (Malta)

^g GALLIERA HOSPITAL   (Italy)

^h UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN ALPHA CHAIN; HEMOGLOBIN BETA CHAIN; HEMOGLOBIN F; HEMOGLOBIN GAMMA CHAIN; SPACER DNA;

ARTICLE; BETA THALASSEMIA; DISEASE SEVERITY; DNA POLYMORPHISM; DNA SEQUENCE; FEMALE; GENE LOCUS; GENETIC ANALYSIS; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MUTATION; PHENOTYPE; POLYMERASE CHAIN REACTION; SCORING SYSTEM; BETA-THALASSEMIA; BLOOD TRANSFUSION; CLINICAL TRIAL; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENETICS; KAPLAN MEIER METHOD; MORTALITY; PROGNOSIS; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; SINGLE NUCLEOTIDE POLYMORPHISM;

BETA-GLOBINS; BETA-THALASSEMIA; BLOOD TRANSFUSION; DNA, INTERGENIC; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC LOCI; GENETIC VARIATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MUTATION; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84926314486     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2014.113886     Document Type: Article

References (22)

1. Cao A, Galanello R. Cao A, Galanello R. Beta-Thalassemia. In: Pagon RA, Bird TC, Dolan CR, Stephens K, editors. GeneReviews [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2000 [updated 2010].
2. Danjou F, Anni F, Galanello R. Beta-thalassemia: from genotype to phenotype. Haematologica. 2011;96(11):1573-1575.
3. Gilman J, Huisman T. DNA sequence variation associated with elevated fetal G gamma globin production. Blood. 1985; 66(4):783-787.
4. Labie D, Dunda-Belkhodja O, Rouabhi F, et al. The-158 site 5’ to the G gamma gene and G gamma expression. Blood. 1985;66(6): 1463-1465.
5. Garner C, Tatu T, Reittie JE, et al. Genetic influences on F cells and other hematologic variables: a twin heritability study. Blood. 2000;95(1):342-346.
6. Lettre G, Sankaran VG, Bezerra MAC, et al. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc Natl Acad Sci USA. 2008;105(33):11869-11874.
7. Sedgewick AE, Timofeev N, Sebastiani P, et al. BCL11A is a major HbF quantitative trait locus in three different populations with beta-hemoglobinopathies. Blood Cells Mol Dis. 2008;41(3):255-258.
8. So C-C, Song Y-Q, Tsang ST, et al. The HBS1L-MYB intergenic region on chromosome 6q23 is a quantitative trait locus controlling fetal haemoglobin level in carriers of beta-thalassaemia. J Med Genet. 2008; 45(11):745-751.
9. Creary LE, Ulug P, Menzel S, et al. Genetic variation on chromosome 6 influences F cell levels in healthy individuals of African descent and HbF levels in sickle cell patients. PloS One. 2009;4(1):e4218.
10. Menzel S, Thein SL. Genetic architecture of hemoglobin F control. Curr Opin Hematol. 2009;16(3):179-186.
11. Galanello R, Sanna S, Perseu L, et al. Amelioration of Sardinian beta0 thalassemia by genetic modifiers. Blood. 2009; 114(18):3935-3937.
12. Badens C, Joly P, Agouti I, et al. Variants in genetic modifiers of -thalassemia can help to predict the major or intermedia type of the disease. Haematologica. 2011; 96(11):1712-1714.
13. Danjou F, Anni F, Perseu L, et al. Genetic modifiers of β-thalassemia and clinical severity as assessed by age at first transfusion. Haematologica. 2012;97(7):989-993.
14. Menzel S, Garner C, Gut I, et al. A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15. Nat Genet. 2007; 39(10):1197-1199.
15. Galarneau G, Palmer CD, Sankaran VG, et al. Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation. Nat Genet. 2010;42(12):1049-1051.
16. Solovieff N, Milton JN, Hartley SW, et al. Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 5’ olfactory receptor gene cluster. Blood. 2010;115(9):1815-1822.
17. Bhatnagar P, Purvis S, Barron-Casella E, et al. Genome-wide association study identifies genetic variants influencing F-cell levels in sickle-cell patients. J Hum Genet. 2011; 56(4):316-323.
18. Farrell JJ, Sherva RM, Chen Z-Y, et al. A 3-bp deletion in the HBS1L-MYB intergenic region on chromosome 6q23 is associated with HbF expression. Blood. 2011; 117(18):4935-4945.
19. Galanello R, Sollaino C, Paglietti E, et al. Alpha-thalassemia carrier identification by DNA analysis in the screening for thalassemia. Am J Hematol. 1998;59(4):273-278.
20. Sutton M, Bouhassira EE, Nagel RL. Polymerase chain reaction amplification applied to the determination of beta-like globin gene cluster haplotypes. Am J Hematol. 1989;32(1):66-69.
21. Ladis V, Chouliaras G, Berdoukas V, et al. Survival in a large cohort of Greek patients with transfusion-dependent beta thalassaemia and mortality ratios compared to the general population. Eur J Haematol. 2011;86(4):332-338.
22. Cao A, Kan YW. The prevention of thalassemia. Cold Spring Harb Perspect Med. febbraio 2013;3(2):a011775.